Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Olanzapine injection to be discontinued in UK Olanzapine injection, powder for reconstitution 5mg/mL, 10mg vial (Zyprexa; Lilly), is to be discontinued in theUK31st August 2012, for sales volume reasons. There is no generic or alternative […]
Latest articles
SHORTCUTS
Articles of interest in other scholarly journals. Meta-analysis: non-steroidal anti-inflammatory drugs in biliary colic. Colli A, Conte D, Valle SD, Sciola V, Fraquelli M. This systematic review with meta-analysis assessed the analgesic benefits and reduction of complications, as well as the potential harms from randomised clinical trials (RCTs) evaluating non-steroid anti-inflammatory drugs (NSAIDs) in […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics FDA approve REMS for m/r opioids USFood and Drug administration (FDA) has approved a Risk Evaluation and Mitigation Strategy (REMS) program for all modified-release (m/r) opioids. Key components include prescriber training, updated patient information guides […]
Should palliative care play a role in the management and treatment of diabetes?
New research published this week in the Journal of General Internal Medicine indicates that palliative care could play an important role in the management of type 2 diabetes. The study, conducted by a team of researchers in California, analysed the symptom burden and survival times of over 13,000 diabetic adults aged 30-75. The results indicated […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates NICE consultation on denosumab The National Institute for Health and Clinical Excellence (NICE) has issued a second appraisal consultation document on the use of denosumab as a treatment to delay or prevent skeletal-related events […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics BNF now available as a free smartphone app Health professionals can now access the British National Formulary (BNF) from a smartphone via a new application (app) from the National Institute for Health and Clinical […]
Results of the UK’s first National Bereavement Survey released
Today saw the publication of the results from the UK’s first National Bereavement Survey. The questionnaire, which was administered in November 2011, aimed to establish what the standard of end-of-life care was, as seen through the eyes of people who had lost a loved-one. The responses of over 22,000 people were collated and the results […]
The transition from childhood to adult palliative care: A time for action
Young people with palliative care needs from across the UK are today lobbying the government to change the way that the transition from childhood to adult palliative care services is handled. Currently, support for children with life-limiting conditions comes to an abrupt end at the age of either 16 or 18. Services for adults – […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Study published on the impact of co-proxamol withdrawal A time series study on the impact of co-proxamol withdrawal on prescribing and deaths in the UKhas been published. The study concludes that during the 6 […]
The BMJ’s new stance on assisted dying
The BMJ recently expressed its support for the notion that the UK’s leading medical bodies, including the BMA and Royal Colleges, abandon their opposition to assisted dying in favour of a neutral stance. The move comes as a recent poll undertaken by Dignity in Dying revealed that of 1000 GPs surveyed, 62% supported a shift […]